Cargando…
Genomewide Pharmacogenomic Analysis of Response to Treatment with Antipsychotics
Schizophrenia is an often devastating neuropsychiatric illness. Understanding the genetic variation affecting response to antipsychotics is important to develop novel diagnostic tests to match individual schizophrenic patients to the most effective and safe medication. Here we use a genomewide appro...
Autores principales: | McClay, Joseph L., Adkins, Daniel E., Åberg, Karolina, Stroup, Scott, Perkins, Diana O., Vladimirov, Vladimir I., Lieberman, Jeffrey A., Sullivan, Patrick F., van den Oord, Edwin J.C.G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888895/ https://www.ncbi.nlm.nih.gov/pubmed/19721433 http://dx.doi.org/10.1038/mp.2009.89 |
Ejemplares similares
-
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
por: Adkins, Daniel E., et al.
Publicado: (2010) -
Genome-wide association study of antipsychotic induced QTc interval prolongation
por: Åberg, Karolina, et al.
Publicado: (2010) -
Estimation of CpG coverage in whole methylome next-generation sequencing studies
por: van den Oord, Edwin JCG, et al.
Publicado: (2013) -
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR(*)D
por: Adkins, D E, et al.
Publicado: (2012) -
Genomewide Association Studies in Pharmacogenomics
por: McInnes, Gregory, et al.
Publicado: (2021)